Aspen Neuroscience
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1/2a Study of ANPD001 in Parkinson Disease (NCT06344026) | Aspen Neuroscience | 2024-01-23 |
Track Aspen Neuroscience automatically
Every clearance here is in the API, with alerts when new ones post.